Interleukin-27 directly induces differentiation in hematopoietic stem cells.

Interleukin (IL)-27, one of the most recently discovered IL-6 family cytokines, activates both the signal transducer and activator of transcription (STAT)1 and STAT3, and plays multiple roles in pro- and anti-inflammatory immune responses. IL-27 acts on various types of cells including T, B, and macrophage through the common signal-transducing receptor gp130 and its specific receptor WSX-1, but the effect of IL-27 on hematopoietic stem cells (HSCs) remains unknown. Here, we show that IL-27 together with stem cell factor (SCF) directly acts on HSCs and supports their early differentiation in vitro and in vivo. CD34(-/low)c-Kit(+)Sca-1(+)lineage marker(-) (CD34(-)KSL) cells, a population highly enriched in mouse HSCs, were found to express both IL-27 receptor subunits. In vitro cultures of CD34(-)KSL cells with IL-27 and SCF resulted in an expansion of progenitors including short-term repopulating cells, while some of their long-term repopulating activity also was maintained. To examine its in vivo effect, transgenic mice expressing IL-27 were generated. These mice exhibited enhanced myelopoiesis and impaired B lymphopoiesis in the bone marrow with extramedullary hematopoiesis in the spleen. Moreover, IL-27 similarly acted on human CD34(+) cells. These results suggest that IL-27 is one of the limited cytokines that play a role in HSC regulation.

[1]  H. Nakauchi,et al.  Adult mouse hematopoietic stem cells: purification and single-cell assays , 2006, Nature Protocols.

[2]  D. Levy,et al.  STAT 3 positively regulates an early step in B-cell development , 2006 .

[3]  D. Danilenko,et al.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells , 2006, Nature Immunology.

[4]  K. Takeda,et al.  IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 31 , 2006, The Journal of Immunology.

[5]  P. Kincade,et al.  Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells. , 2005, Blood.

[6]  C. Hunter.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[7]  A. Iwama,et al.  Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. , 2004, Immunity.

[8]  T. Yoshimoto,et al.  An Indispensable Role for STAT1 in IL-27-Induced T-bet Expression but Not Proliferation of Naive CD4+ T Cells1 , 2004, The Journal of Immunology.

[9]  Y. Iwakura,et al.  Induction of IgG2a Class Switching in B Cells by IL-271 , 2004, The Journal of Immunology.

[10]  T. Mcclanahan,et al.  WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.

[11]  Maria Laura Belladonna,et al.  Potent Antitumor Activity of Interleukin-27 , 2004, Cancer Research.

[12]  T. Mak,et al.  The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. , 2003, Immunity.

[13]  R. Kastelein,et al.  IL-27 and IFN-α Signal via Stat1 and Stat3 and Induce T-Bet and IL-12Rβ2 in Naive T Cells , 2003 .

[14]  武田 篤信.  Cutting edge : Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment , 2003 .

[15]  T. Hirano,et al.  IL-6 signal transduction and its physiological roles: the signal orchestration model. , 2003, Reviews of physiology, biochemistry and pharmacology.

[16]  R. de Waal Malefyt,et al.  IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  A. Iwama,et al.  Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis. , 2002, Blood.

[18]  T. Mcclanahan,et al.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.

[19]  L. Naeger,et al.  Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. , 2002, Immunity.

[20]  A. D. Panopoulos,et al.  Control of Myeloid-specific Integrin αMβ2 (CD11b/CD18) Expression by Cytokines Is Regulated by Stat3-dependent Activation of PU.1* , 2002, The Journal of Biological Chemistry.

[21]  A. D. Panopoulos,et al.  Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. , 2002, The Journal of biological chemistry.

[22]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[23]  T. Mak,et al.  WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. , 2001, Immunity.

[24]  H. Nakauchi,et al.  Age-Associated Characteristics of Murine Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[25]  J. Audet,et al.  High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. , 2000, Blood.

[26]  R. Jove,et al.  Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors , 1999, Oncogene.

[27]  M. Katsuki,et al.  STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.

[28]  S. Rose-John,et al.  Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. , 1998, Blood.

[29]  T. Graf,et al.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. , 1998, Genes & development.

[30]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[31]  S. Lyman,et al.  c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. , 1998, Blood.

[32]  A. Roberts,et al.  Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Miyazaki,et al.  Reduced T helper 1 responses in IL-12 p40 transgenic mice. , 1998, Journal of immunology.

[34]  Cindy L. Miller,et al.  Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Ogawa,et al.  In vitro expansion of hematopoietic stem cells , 1997, Stem cells.

[36]  D. Chaplin,et al.  Lymphotoxin‐α‐deficient and TNF receptor‐I‐deficient mice define developmental and functional characteristics of germinal centers , 1997, Immunological reviews.

[37]  M. Ogawa,et al.  In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand. , 1997, Blood.

[38]  P. Schirmacher,et al.  Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice , 1997, The Journal of experimental medicine.

[39]  S. Rose-John,et al.  A bioactive designer cytokine for human hematopoietic progenitor cell expansion , 1997, Nature Biotechnology.

[40]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[41]  Andrew W. Murray,et al.  Association of Spindle Assembly Checkpoint Component XMAD2 with Unattached Kinetochores , 1996, Science.

[42]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[43]  Hiromitsu Nakauchi,et al.  Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.

[44]  T. Holyoake,et al.  Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. , 1996, Blood.

[45]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[46]  K. Shiota,et al.  Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Ware,et al.  Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. , 1995, Development.

[48]  A. Bernad,et al.  Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. , 1994, Immunity.

[49]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[50]  R. Cardiff,et al.  Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. , 1994, The EMBO journal.

[51]  P. Brûlet,et al.  Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation , 1993, Nature.